Medicare Enrolled

Dr. Peter Lewitt, M.D.

Neurology · West Bloomfield, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
6777 W MAPLE RD, West Bloomfield, MI 48322
2483252452
In practice since 2007 (19 years)
NPI: 1750434114 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lewitt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lewitt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lewitt

Dr. Peter Lewitt is a neurology specialist in West Bloomfield, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lewitt performed 162 Medicare services across 131 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lewitt received a total of $402,516 from 31 pharmaceutical and/or device companies across 408 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lewitt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 162 Medicare services $402,516 industry payments

Medicare Practice Summary

Medicare Utilization ↗
162
Medicare services
Bottom 30% in MI for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
131
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
78 $69 $164
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 30 $14 $63
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
26 $113 $212
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
17 $107 $192
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
11 $42 $156
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$402,516
Total received (2018-2024)
Avg $57,502/year across 7 years
Top 2% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
408
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$256,148 (63.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$144,470 (35.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,898 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,211
2023
$21,353
2022
$19,147
2021
$90,830
2020
$64,937
2019
$127,828
2018
$76,209

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Genentech, Inc.
$1,200
ABBVIE INC.
$318
Amneal Pharmaceuticals LLC
$257
MDD US Operations, LLC
$133
Ipsen Biopharmaceuticals, Inc
$114
Neurocrine Biosciences, Inc.
$98
Kyowa Kirin, Inc.
$72
ACADIA Pharmaceuticals Inc
$20
Top 3 companies account for 80.3% of 2024 payments
All-time payments by company (2018-2024) ›
US WorldMeds, LLC
$95,521
Kyowa Kirin, Inc.
$73,705
Acorda Therapeutics, Inc
$69,089
Amneal Pharmaceuticals LLC
$35,373
MDD US Operations, LLC
$35,086
Neurocrine Biosciences, Inc.
$21,912
Otsuka America Pharmaceutical, Inc.
$13,961
JAZZ PHARMACEUTICALS INC.
$9,680
Biogen, Inc.
$8,046
PFIZER INC.
$7,622
Merz North America, Inc.
$6,305
ACADIA Pharmaceuticals Inc
$5,332
F. Hoffmann-La Roche AG
$4,840
Genentech, Inc.
$4,095
CIPLA USA INC.
$3,348
Lundbeck LLC
$2,048
Supernus Pharmaceuticals, Inc.
$1,500
Sage Therapeutics, Inc.
$1,170
Dr.Reddy's Laboratories,Inc.
$680
Sunovion Pharmaceuticals Inc.
$622
Neurocrine BioSciences, Inc.
$530
Tolmar, Inc.
$500
Vertex Pharmaceuticals Incorporated
$427
ABBVIE INC.
$318
BOSTON SCIENTIFIC CORPORATION
$286
Ipsen Biopharmaceuticals, Inc
$149
GE HealthCare
$109
Alnylam Pharmaceuticals Inc.
$107
Mitsubishi Tanabe Pharma America, Inc.
$62
Medtronic USA, Inc.
$46
Boston Scientific Corporation
$46
Top 3 companies account for 59.2% of all-time payments
Associated products mentioned in payments ›
ACTIVA · AMVUTTRA · APOKYN · BOTOX · CREXONT · DAYBUE · DYSPORT · Dysport · GENERAL DBS · GENERAL DBS · GENERAL DBS · GOCOVRI · Gocovri · INBRIJA · INGREZZA · ISTRADEFYLLINE · KYNMOBI · MYOBLOC · NORTHERA · NOURIANZ · NUPLAZID · Non-Covered Product · Nourianz · ONGENTYS · Ongentys · RYTARY · Radicava · SUNOSI · UBRELVY · VYALEV · XEOMIN · Xadago
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for neurology in MI.

Looking for a neurology specialist in West Bloomfield?
Compare neurologists in the West Bloomfield area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
347
Per 100K population
27.3
County median income
$95,296
Nearest hospital
HENRY FORD HEALTH WEST BLOOMFIELD HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lewitt is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lewitt experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lewitt performed 78 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lewitt receive payments from pharmaceutical companies?
Yes. Dr. Lewitt received a total of $402,516 from 31 companies across 408 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lewitt's costs compare to other neurologists in West Bloomfield?
Dr. Lewitt's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lewitt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →